Phase 3
Completed N=156
Treatments for Depression: Drug Versus Psychotherapy
Source: ClinicalTrials.gov NCT00043550 ↗Enrolled (actual)
156
Serious AEs
0.0%
Results posted
Jun 2017
Primary outcomePrimary: Hamilton Rating Scale for Depression-17 Item — 19.0; 19.9; 19.4; 13.9 units on a scale — p=.95
Summary
This 4-8 month study, with a 2-year follow up period, will compare sertraline (Zoloft®), venlafaxine (Effexor®), supportive-expressive psychotherapy, and placebo to determine which is more effective in treating major depression.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Hamilton Rating Scale for Depression-17 Item |
19.0; 19.9; 19.4; 13.9; 12.5; 12.7 | .95 |
Eligibility Criteria
Inclusion criteria
- Major Depressive Disorder diagnosis
Exclusion criteria
- Psychotic or bipolar disorder diagnosis
- Substance dependence in the last 6 months
Data sourced from ClinicalTrials.gov (NCT00043550). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.